• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LI Yuyao, SONG Heng, CHENG Jian, AO Guizhen. Synthesis and biological evaluation of H2S donor ADT-OH derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(3): 276-281. DOI: 10.11665/j.issn.1000-5048.20170304
Citation: LI Yuyao, SONG Heng, CHENG Jian, AO Guizhen. Synthesis and biological evaluation of H2S donor ADT-OH derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(3): 276-281. DOI: 10.11665/j.issn.1000-5048.20170304

Synthesis and biological evaluation of H2S donor ADT-OH derivatives

More Information
  • 5-(4-Hydroxyphenyl)-3H-1, 2-dithiole-3-thione(ADT-OH)is a slowly releasing H2S donor with some neuroprotective effect. In order to study the structure-activity relationships, seventeen compounds( Y1 - Y17 )were synthesized by modification of ADT-OH at the aromatic ring position, and their structures were confirmed by 1H NMR, 13C NMR and HR-MS. Among them, 6 compounds( Y4, Y13 - Y17 )were novel compounds. Their effects had been evaluated on HT-22 hippocampal neuron cells damaged by glutamate with MTT method. The pharmacological results demonstrated that all the Y compounds had potent neuroprotection at most of the tested concentrations(1-100 μmol/L). Compounds Y1 - Y9 and Y11 significantly improved the survival rates of the damaged cells at 1-100 μmol/L(P<0. 01). Specially, compounds Y1, Y4, Y6 - Y9, Y11 are more potent than their parent compound ADT-OH at concentration of 1-10 μmol/L, which is worthy of further study.
  • [1]
    Deb P,Sharma S,Hassan KM.Pathophysiologic mechanisms of acute ischemic stroke:an overview with emphasis on therapeutic significance beyond thrombolysis[J].Pathophysiology,2010,17(3):197-218.
    [2]
    Viscoli CM,Brass LM,Carolei A,et al.Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack:rationale and design of the insulin resistance intervention after stroke trial[J].Am Heart J,2014,168(6):823-829.
    [3]
    Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models,pathophysiology,and therapy of focal cerebral ischemia[J].Pharm Biochem Behav,2007,87(1):179-197.
    [4]
    Cheng J,Ao GZ,Jia J,et al.Differential mechanisms underlying neuroprotection of hydrogen sulfide donors against oxidative stress[J].Neurochem Int,2013,62(8):1072-1078.
    [5]
    Ao GZ,Jia J,Cheng J,et al.CaMKKβ-dependent activation of AMP-activated protein kinase is critical to suppressive effects of hydrogen sulfide on neuroinflammation[J].Antioxid Redox Signal, 2014,21(12):1741-1758.
    [6]
    Wang Y,Jia J,Ao GZ,et al.Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia[J].J Neurochem,2014,129(5):827-838.
    [7]
    Sun YX,Wu Y,Song H,et al.Synthesis and biological evaluation of H2S donor memantine derivatives[J].J China Pharm Univ(中国药科大学学报),2016,47(5):543-547.
    [8]
    Borowiecki P,Bretner M.Studies on the chemo enzymatic synthesis of(R)-and(S)-methyl 3-aryl-3-hydroxypropionates:the influence of toluene-pretreatment of lipase preparations on enantioselective transesterifications[J].Tetrahedron Asymmetry,2013,24(15/16):925-936.
    [9]
    Wang X,Wang L,Sheng X,et al.Design,synthesis and biological evaluation of hydrogen sulfide releasing derivatives of 3-n-butylphthalide as potential antiplatelet and antithrombotic agents[J].Org Biomol Chem,2014,12(31):5995-6004.
    [10]
    Rothman SM,Olney JW.Glutamate and the pathophysiology of hypoxic-ischemic brain damage[J].Ann Neurol,1986,19(2):105-110.
    [11]
    Van LK,Siddiq A,Ratan RR,et al.Proteasome inhibition protects HT22 neuronal cells from oxidative glutamate toxicity[J].J Neurochem,2005,92(4):824-830.

Catalog

    Article views (952) PDF downloads (1947) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return